Top by categoryEvery category ranked by need: services, software and firms.
Top software by featureThe best tools for one job, across every software category.
Top companies by countryThe leading B2B firms in each country, category by category.
Popular software rankings
Top Inventory Management Software
Top Supplier Management Software
Top Fleet Management Software
Top Cloud Storage Backup Software
Top Master Data Management Software
Top Document Storage Software
Top 3D Modeling Software
Top Compliance Tracking Software
See all popular software rankings
Popular category rankings
Top Software Development Companies
Top Digital Marketing Companies
Top App Development Companies
Top Web Design Agencies
Top Accounting Firms
Top Recruitment Agencies
Top Advertising Companies
Top Design Agencies
See all popular category rankings
Top companies by country
Top companies in the UK
Top companies in the USA
Top companies in India
Top companies in Canada
Top companies in Australia
Top companies in Germany
Top companies in the UAE
Top companies in Pakistan
See all top companies by country
All rankings All categories How we rank
Sectors

Venture capital firm

Vesalius Biocapital III

European life sciences venture capital investor backing later-stage healthcare companies

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

Vesalius Biocapital III cover

TrustList summary

Vesalius Biocapital III is a fund run by Vesalius Biocapital, a European life sciences venture capital investor. The fund closed in May 2019 and is now in its investment phase.

Products and services

Drug development investment: backs companies developing new medicines.
Medical devices and diagnostics: invests in tools that meet unaddressed medical needs.
Digital health: includes eHealth and mHealth businesses.

Customers and markets

Mostly later-stage life sciences companies in Europe. Its portfolio firms address unmet medical and market needs and rely on strong intellectual property protection.

Key facts

Region: predominantly Europe
Fund vintage: 2017
Final closing: May 2019
Status: in investment mode

Summary written by TrustList from the business's own published information, Oct 2026.

Gallery

2 images - click to enlarge

Ask TrustList to introduce you to Vesalius Biocapital III

Reviews

Write the first review of Vesalius Biocapital III

Used it? Your experience helps other buyers decide.

Questions & answers

No questions yet. Be the first to ask about Vesalius Biocapital III.

Vesalius Biocapital III alternatives

Similar listings buyers compare against this one.

Compare side by side

Zoovu

Product discovery software for B2B and B2C sellers, covering search, guided selling and product content

Compare

AIM Group

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Compare

Y Combinator

Startup accelerator and early-stage investor running intensive batches for new technology founders

Compare

SOSV

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Compare

Andreessen Horowitz (a16z)

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Compare

Sentinel

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications

Compare

HI

Hallador Investment Advisors

Reno family office and SEC-registered investment adviser serving one family and institutional clients

Compare

UC

Univen Capital

Venture capital company financing portfolio businesses and advising them on strategy and capital deals

Compare

Keep exploring

More on TrustList

Everything here links back to the same verified catalogue. Pick your next stop.